MYGEM GEMCITABINE INJECTION

Get a Price/Quote

MOQ : 1 Bottle

MYGEM GEMCITABINE INJECTION Specification

Salt Composition
Gemcitabine 1g or 200mg per vial (as hydrochloride)

Pacakaging (Quantity Per Box)
1 vial per box

Indication
Pancreatic cancer, non-small cell lung cancer, breast cancer, ovarian cancer, bladder cancer

Dosage Form
Injection

Origin of Medicine
India

Drug Type
Allopathic

Ingredients
Gemcitabine Hydrochloride

Physical Form
Liquid

Function

Recommended For
As directed by oncologist for specific malignancies

Dosage
As prescribed by the physician

Dosage Guidelines
Administer through intravenous infusion, as per medical advice.

Suitable For
Adults

Quantity
1 vial

Storage Instructions
Store below 25C. Protect from light.

MYGEM GEMCITABINE INJECTION Trade Information

Minimum Order Quantity
1 Bottle

Packaging Details
PACK OF SINGLE DOSE OF VIAL

About MYGEM GEMCITABINE INJECTION

PRODUCT DETAILS

Brand Name: MYGEM
Content: Gemcitabine injection
Strengths:200 Mg & 1 g
Form: VIAL
Packing: single dose vial
Manufactured By: Mylan

Note :- MYGEM Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug.............

Precise Dosage and Administration

MYGEM Gemcitabine Injection is administered intravenously by healthcare professionals within hospitals or specialized institutions. Dosage and schedule are determined individually by oncologists according to the patients cancer type and treatment plan. The medication must be stored below 25C and is to be used as a single dose, ensuring safety and effectiveness.

Targeted Therapeutic Use

This injection is suitable for adults diagnosed with pancreatic, non-small cell lung, breast, ovarian, and bladder cancers. Its primary function is to inhibit the growth and spread of cancer cells. Use is strictly based on a physicians prescription, reflecting the importance of controlled, professional supervision for optimum results and minimal risk.

Stringent Quality and Regulatory Compliance

Manufactured in India and approved by Indian regulatory authorities, MYGEM meets high standards for safety, efficacy, and quality. Each vial contains either 1g or 200mg of Gemcitabine Hydrochloride, presented in secure packaging for single-use. Its clear, colorless physical form underscores its pharmaceutical purity and compliance.

FAQs of MYGEM GEMCITABINE INJECTION:

Q: How should MYGEM Gemcitabine Injection be administered?

A: MYGEM should be administered exclusively as an intravenous infusion by qualified healthcare professionals in a hospital or institutional setting. Never attempt to self-administer this medication.

Q: What conditions does MYGEM Gemcitabine Injection treat?

A: MYGEM is prescribed for adults with malignant conditions such as pancreatic cancer, non-small cell lung cancer, breast cancer, ovarian cancer, and bladder cancer, according to an oncologists assessment.

Q: When is the best time to use MYGEM Gemcitabine Injection?

A: MYGEM must be used strictly on the schedule and frequency recommended by your treating oncologist. The timing and interval of doses depend on the specific cancer type and the patients clinical response.

Q: Where should MYGEM Gemcitabine Injection be stored?

A: The injection should be stored below 25C and protected from direct light. Ensure it is kept out of reach of children and only handled by qualified medical personnel.

Q: What is the process for receiving MYGEM Gemcitabine Injection?

A: Upon a physicians prescription, the injection is administered intravenously by a healthcare professional in a hospital or institutional facility, tailored to your diagnosis and treatment protocol.

Q: How does MYGEM Gemcitabine Injection benefit patients?

A: MYGEM acts as a chemotherapeutic agent, helping to slow or stop the growth of cancer cells, thereby supporting patients cancer management and improving clinical outcomes.

Q: What safety precautions should be followed during MYGEM administration?

A: Administration should only occur under strict medical supervision in a hospital. Regular monitoring is crucial, and patients should promptly report any side effects to their medical team.

Tell us about your requirement